報價延遲最少15分鐘:2025/01/21 18:50 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.91 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.74/0.52
|
|
企業價值
104.75M
|
| 資產負債 |
|
每股賬面淨值
1.44
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
16.03M
|
|
每股收益
1.66
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 18:50 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated withmigraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients. |